4//SEC Filing
Dudley Robert Michael 4
Accession 0001104659-23-070804
CIK 0001829635other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:16 PM ET
Size
5.1 KB
Accession
0001104659-23-070804
Insider Transaction Report
Form 4
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2023-06-09$2.76/sh+19,000$52,440→ 912,114 total
Footnotes (1)
- [F1]Reflects the weighted average purchase price for shares of common stock purchased. Actual purchase prices for the shares purchased ranged from $2.675 to $2.85. The Reporting Person undertakes to provide TransCode Therapeutics, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Transcode Therapeutics, Inc.
CIK 0001829635
Entity typeother
Related Parties
1- filerCIK 0001854161
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:16 PM ET
- Size
- 5.1 KB